The US continues to be the dominant leader in the field of biotechnology. Discovery and innovation have resulted in significant enhancements to our quality of life and contributed considerably to our current economic posture making American biotechnology the benchmark for society. As we enter the next century, our robust economy will continue to be the preeminent pillar of our National Security Strategy with biotechnology playing a key role in sustaining the US economy. However, success within the biotechnology industry does not come without failure. The industry is undergoing a dynamic period of competition, cooperation, and collaboration as it struggles to achieve economic efficiencies. Governments and industry are achieving significant progress, but problems relating to international acceptance, financing, and the more difficult ethical arguments remain.
ICAF Industry Studies 1998